Subscribe to our Newsletters !!
On September 16, 2024, HiMedia Laboratories proudl
Particles in suspensions are abundant in biologica
Dräger India is proud to announce the launch of t
Husky Technologies™ is excited to announce a maj
Alembic Pharmaceuticals Limited (Alembic) today an
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of Micr
Gene and cell treatment firm Oxford Biomedica plc said on Monday it had named French pharmaceutical industry veteran Roch Doliveux as its non-official administrator, as it eyes a possibly significant job in delivering coronavirus antibody.
Doliveux, who right now fills in as a non-official chief at Stryker Corp, will take up his job at Oxford from June 24, the organization said.
A week ago, AstraZeneca reported an association with Oxford to make its test COVID-19 immunization as the drugmaker hopes to support its assembling ability to deliver one billion dosages.
